AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • April 16th, 2020 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 16th, 2020 Company Industry JurisdictionThis Amendment to Note Purchase Agreement, dated as of April 10, 2020 (this “Amendment Agreement”) is made by and among IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), each of the Subsidiary Guarantors set forth on the signature pages to this Amendment Agreement (together with the Company, collectively, the “Credit Parties”) and each of the holders of the Notes (as defined below) set forth on the signature pages to this Amendment Agreement (collectively, the “Noteholders”) in accordance with Section 17 of the Note Purchase Agreement (as hereinafter defined).
AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • April 16th, 2020 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 16th, 2020 Company Industry JurisdictionThis Amendment to Note Purchase Agreement, dated as of April 10, 2020 (this “Amendment Agreement”) is made by and among IDEXX Laboratories, Inc., a Delaware corporation (the “Company”), each of the Subsidiary Guarantors set forth on the signature pages to this Amendment Agreement (together with the Company, collectively, the “Credit Parties”) and each of the holders of the Notes (as defined below) set forth on the signature pages to this Amendment Agreement (collectively, the “Noteholders”) in accordance with Section 17 of the Note Purchase Agreement (as hereinafter defined).